Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 36.20
-0.20 (-0.55%)
At close: Mar 27, 2026
Biosergen AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
85.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 296.57M |
| Alzinova AB | 26.80M |
| Scandinavian ChemoTech AB | 12.29M |
| Biovica International AB | 10.93M |
| AcouSort AB | 10.43M |
| Spago Nanomedical AB | 4.82M |
| Alligator Bioscience AB | 4.42M |
| OncoZenge AB | 2.78M |